Skip to content

Lung Cancer Blog

Everything about lung cancer is here.

Menu
  • Home
  • About Us
  • Lung Cancer
    • Lung Cancer News
    • Causes of Lung Cancer
    • Lung Cancer Symptoms
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Lung Cancer Treatment
    • Lung Cancer Drugs
    • Lung Cancer In Ayurveda
    • Chinese Herbs For Lung Cancer
  • Researches
  • Studies
  • Stories
  • Sitemap
  • Contact Us
Menu
Non-Small-Cell Lung Cancer (NSCLC)

Combination Of Radiation And Immunotherapy For Advanced Non-Small Cell Lung Cancer

Posted on January 22, 2024
Post Views: 265

Non-Small-Cell Lung Cancer (NSCLC)According to the new study by researchers from the UCLA Health Jonsson Comprehensive Cancer Center, using high doses of radiation with an ablative radiotherapy technique is effective for treatment with locally advanced non-small cell lung cancer that is not suitable for surgery. The findings are published in the Journal JAMA Oncology.

In this study, the team has found that the combination treatment to apply Stereotactic Ablative Radiotherapy (SABR) along with chemotherapy helps in reducing both toxic side effects and the likelihood of return of cancer. The ULCA team enrolled 28 patients in their study who had either Stage II or III NSCLC. They received a base radiation dose of 4 Gy x 10 fractions and then an SABR boost to target any remaining metabolically active cancer. All patients were given concurrent weekly chemotherapy as well. In this approach, the most promising results were seen in the cohort that received the intermediate dose. The patients received a total of 70Gy in 15 fractions including a 30 Gy boost.

Though most patients experienced some adverse effects like fatigue, sore throat and cough, inflammation of lungs etc. but did not exhibit any severe side effects from their treatment. After a period of two years, the local control rates were 74.1%, 85.7% and 100% for low, intermediate and high dose cohorts. The survival rate was 30%, 76.2% and 55.6% respectively.

“Our data shows patients may benefit from targeted, high-dose radiation with chemotherapy if it’s done thoughtfully with adaptive radiation,” said Beth Neilsen, MD, an author of the study and a radiation oncology resident at UCLA. The limitations of the study were the small study size and follow-up period. The promising results of this study will spur future trials to include consolidation immunotherapy in the treatment setting.

The information shared in this blog is for educational purposes only. You should always ask your healthcare provider for any medical needs.

Subscribe to our newsletter or follow us on Facebook or Twitter today and never miss out an update!

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Telegram (Opens in new window) Telegram

Like this:

Like Loading...

Subscribe Us

Popular Articles

  • Lung Cancer Treatment in Ayurveda (7,322)
  • Lung Cancer: Symptoms and Treatment (5,655)
  • What is Non-Small-Cell Lung Cancer? (5,551)

Recent Comments

  • Lung Cancer on New Study To Help Advance Research In Lung Cancer
  • Laurie B Grimes on New Study To Help Advance Research In Lung Cancer
  • Lung Cancer on Asbestos and Lung Cancer – What’s The Link?

Recent Articles

  • Study: Wildfire Smoke Exposure Affects Lung Cancer Survival June 2, 2025
  • Predicting Lung Cancer Risk with AI based Deep Learning Model May 26, 2025
  • FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC May 19, 2025
  • Heart-Sparing Technique in Lung Cancer Radiotherapy May 12, 2025
  • Origins of Common Lung Cancer Linked to Smoking Discovered May 5, 2025

Lung Cancer Blog

Lung Cancer Blog provides all lung cancer related information for educational purposes.

Disclaimer

Some post may contain affiliate links, purchasing that product not going to cost extra but by your purchase Lung Cancer will get some little commission and that amount will help in surviving this website. So, please don’t hesitate to buy from these affiliate links.

Contact Us

If you have any query or suggestions about our blog, please feel free to email us at  lungcancersymptomsx@gmail.com.

Copyright © 2012 - 2025 Lung Cancer Blog. Wordpress by Vipasha.
  • Privacy Policy
  • About Us
  • Sitemap
  • Contact Us
%d